Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis.

Benedikt Silvester Hofer Lukas BurghartEmina HalilbasicBenedikt SimbrunnerOleksandr PetrenkoMattias MandorferAlbert Friedrich StättermayerMichael TraunerThomas Reiberger

Published in: Alimentary pharmacology & therapeutics (2024)

Patients with PBC and decompensated cirrhosis may achieve hepatic recompensation under UDCA therapy. However, since liver-related complications still occur after recompensation, patients should remain under close follow-up.

Keyphrases

ejection fraction
heart failure
end stage renal disease
newly diagnosed
chronic kidney disease
prognostic factors
risk factors
stem cells
bone marrow
atrial fibrillation
patient reported